obese diabetic patients: impact of different management modalities

Authors

dampanaboina kavitha division of pharmacology, au college of pharmaceutical sciences, andhra university, visakhapatnam, india

bitra veera raghavulu division of pharmacology, au college of pharmaceutical sciences, andhra university, visakhapatnam, india

akula annapurna division of pharmacology, au college of pharmaceutical sciences, andhra university, visakhapatnam, india

abstract

type 2 diabetes is one of the major public health challenges in 21st century. both environmental changes and genetics are attributed for increased risk of type 2 diabetes. obesity is the most critical and modifiable risk factor and should be targeted for successful management of diabetes. this review article discusses three main approaches to manage obesity. three management modalities considered are lifestyle modifications including dietary counseling, behavior therapy and physical activity/exercise, use of pharmaceutical agents, and bariatric surgery. in most patients, lifestyle interventions produce only modest weight loss and have a diminishing effect over time. if patients are unable to respond lifestyle intervention with a weight loss of 5-10%, adjunctive pharmacological treatment may be considered. a variety of pharmacological agents have been shown to induce weight loss and preserve weight loss for longer, as well as ameliorate cardiovascular risk factors. however, the long term health benefits and safety remain unclear and thus, long term studies powered to examine mortality and cardiovascular morbidity are required. bariatric surgery is the ultimate treatment producing massive weight loss and resolution of type 2 diabetes in nearly 100% of patients. however this is applicable only for patients with significant obesity. successful treatment of most overweight and obese individuals will depend upon the future development of new therapies. it also requires a paradigm shift in viewing obesity as a disease that requires treatment, rather than deferring treatment until the complications develop.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Obese Diabetic Patients: Impact of Different Management Modalities

Type 2 diabetes is one of the major public health challenges in 21st century. Both environmental changes and genetics are attributed for increased risk of type 2 diabetes. Obesity is the most critical and modifiable risk factor and should be targeted for successful management of diabetes. This review article discusses three main approaches to manage obesity. Three management modalities consider...

full text

Perioperative management of obese patients.

Obesity prevalence has quadrupled since the 1980s in the United States. It is estimated that 30% of the population is obese or has a body mass index of greater than or equal to 30 as defined by the World Health Organization. Surgeons are likely to engage in the care of obese patients and need to be adept in every aspect of the patients' care in order to have a successful hospital course. There ...

full text

Acute pancreatitis: Causes, pathophysiology, different modalities of management

Background: This study was intended to throw light upon the topic of acute pancreatitis, its incidence, etiology, pathogenesis as well as its management. Aim and objectives: To review and study the patients who presented with acute pancreatitis, to find out the incidence of acute pancreatitis and study the various etiological factors, to study the various modalities of treatment of acute pancre...

full text

Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management.

Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3 million Americans. It is the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States. Diabetic patients with ESRD have a high incidence of cardiovascular disease and death. For those kidney transplant patients with no history of DM prior to transplantation, the developm...

full text

New modalities for treatment of diabetic nephropathy: a mini review

Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...

full text

The Impact of Biofeedback on Diabetic Patients’ Glycemia

Background: Complementary medicine claims that biofeedback affects the reduction of blood glycemia. Objective: The current study aimed to determine the effects of biofeedback on decreasing blood glucose levels and tension and increasing the quality of life in diabetic patients. Methods: The current retrospective evidence-based study...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of diabetes and obesity

جلد ۴، شماره ۱، صفحات ۳۲-۳۹

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023